Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

JAMA

Volumn 285, Issue 1, 2001, Pages 47-51

  Anttila, Tarja ^a   Saikku, Pekka ^b   Koskela, Pentti ^a   Bloigu, Aini ^a   Dillner, Joakim ^c   Ikäheimo, Irma ^d   Jellum, Egil ^e   Lehtinen, Matti ^f   Lenner, Per ^g   Hakulinen, Timo ^h   Närvänen, Ale ⁱ   Pukkala, Eero ^j   Thoresen, Steinar ^k   Youngman, Linda ^l   Paavonen, Jorma ^h  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF TAMPERE   (Finland)

^g UMEÅ UNIVERSITY   (Sweden)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

^j FINNISH CANCER REGISTRY   (Finland)

^k CANCER REGISTRY OF NORWAY   (Norway)

^l UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER REGISTRY; CANCER RISK; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NORWAY; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; SQUAMOUS CELL CARCINOMA; SWEDEN; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0035798758     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.1.47     Document Type: Article

References (42)

1. Epidemiology of genital human papillomavirus infection
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
4. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ
5. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma
6. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
7. Chlamydia trachomatis infection as a risk for invasive cervical carcinoma
8. Persistent Chlamydiae
9. Persistence of chiamydial antibodies after pelvic inflammatory disease
10. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organism in a new microtiter indirect immunofluorescence test
11. Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies
12. Objectively measured tobacco exposure during pregnancy
13. Experiences of the Janus Serum Bank in Norway
14. A population-based seroepidemiological study of cervical cancer
15. Data quality and quality control of a population-based cancer registry: Experience in Finland
16. Detection of antibodies to Chlamydia trachomatis with peptide based species specific EIA
17. Establishment of a particle-counting method for purified elementary bodies of Chlamydia and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies
18. Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia
19. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
20. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls
21. Three new serovars of Chlamydia trachomatis: Da, la and L2a
22. Association of genital infection with specific Chlamydia trachomatis serovars and race
23. Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington
24. Chlamydia trachomatis immunotypes in Finland
25. Monoclonal antibodies in serovar determination of 53 Chlamydia trachomatis isolates from Amiens France
26. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections
27. Chlamydia trachomatis serovar differentiation by direct sequence of the variable segment 4 region of the major outer membrane protein gene
28. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR
29. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infection and histopathology in San Francisco
30. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection
31. Apparent long term persistence of Chlamydia trachomatis cervical infections: Analysis by OMP1 genotyping
32. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein
33. An inverse relation between cagA strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
34. Detection of multiple serovars of Chlamydia trachomatis in genital infections
35. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners
36. The in situ polymerase chain reaction for detection of Chlamydia trachomatis
37. Colposcopic manifestations of cervical and vaginal infections
38. Inflammation, chromosomal instability, and cancer
39. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells
40. Inhibiton of apoptosis in Chlamydia-infected cells